HM
HealthCor Management’s Edwards Lifesciences EW Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q1 | – | Sell |
-321,200
| Closed | -$29.3M | – | 86 |
|
2020
Q4 | $29.3M | Buy |
321,200
+97,340
| +43% | +$8.88M | 1.13% | 27 |
|
2020
Q3 | $17.9M | Buy |
+223,860
| New | +$17.9M | 0.72% | 27 |
|
2020
Q1 | – | Sell |
-133,210
| Closed | -$31.1M | – | 50 |
|
2019
Q4 | $31.1M | Sell |
133,210
-492,780
| -79% | -$115M | 1.11% | 37 |
|
2019
Q3 | $138M | Buy |
625,990
+3,760
| +0.6% | +$827K | 5.2% | 1 |
|
2019
Q2 | $115M | Buy |
+622,230
| New | +$115M | 4.46% | 3 |
|
2018
Q4 | – | Sell |
-453,715
| Closed | -$79M | – | 40 |
|
2018
Q3 | $79M | Buy |
+453,715
| New | +$79M | 2.62% | 18 |
|
2017
Q4 | – | Sell |
-338,490
| Closed | -$37M | – | 37 |
|
2017
Q3 | $37M | Sell |
338,490
-861,510
| -72% | -$94.2M | 1.24% | 25 |
|
2017
Q2 | $142M | Sell |
1,200,000
-50,000
| -4% | -$5.91M | 5.12% | 4 |
|
2017
Q1 | $118M | Buy |
+1,250,000
| New | +$118M | 5.39% | 5 |
|
2016
Q4 | – | Sell |
-900,000
| Closed | -$109M | – | 43 |
|
2016
Q3 | $109M | Sell |
900,000
-600,000
| -40% | -$72.3M | 6.61% | 4 |
|
2016
Q2 | $150M | Buy |
1,500,000
+675,000
| +82% | +$67.3M | 8.16% | 1 |
|
2016
Q1 | $72.8M | Buy |
825,000
+729,240
| +762% | +$64.3M | 4.12% | 9 |
|
2015
Q4 | $7.56M | Sell |
95,760
-679,240
| -88% | -$53.6M | 0.46% | 33 |
|
2015
Q3 | $110M | Sell |
775,000
-325,000
| -30% | -$46.2M | 6.2% | 2 |
|
2015
Q2 | $157M | Buy |
1,100,000
+850,000
| +340% | +$121M | 7.89% | 1 |
|
2015
Q1 | $35.6M | Buy |
+250,000
| New | +$35.6M | 1.7% | 19 |
|
2013
Q4 | – | Sell |
-500,000
| Closed | -$34.8M | – | 53 |
|
2013
Q3 | $34.8M | Buy |
+500,000
| New | +$34.8M | 1.87% | 21 |
|